SCHEMBL7607748

SCHEMBL7607748

O=C(O)Cc1csc(NP(=O)(O)Cc2ccccc2)c1

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
AKR1B1 P15121 1/20 0.42
RPS6KB2 Q9UBS0 1/20 0.41
MMP12 P39900 2/20 0.38
DAO P14920 1/20 0.36
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
ABCC4 O15439 1/20 0.35
LMNA P02545 1/20 0.35
GAA P10253 1/20 0.35
TSHR P16473 1/20 0.35
PTGS1 P23219 1/20 0.35
HTT P42858 1/20 0.35
HPGD P15428 1/20 0.35
MEN1 O00255 1/20 0.35
ALDH1A1 P00352 1/20 0.35
TP53 P04637 1/20 0.35
KMT2A Q03164 1/20 0.35
NR1H4 Q96RI1 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7610298 0.77 APP (0.37) LMNATSHRPTGS1HPGDMEN1
SCHEMBL7606964 0.73 AKR1B1 (0.42) AKR1B1RPS6KB2MMP12DAOABCC4
SCHEMBL7610525 0.73 MAPK8 (0.40) AKR1B1NPC1RAB9AHPGDMEN1
SCHEMBL7613594 0.72 GABRP (0.46) AKR1B1RAB9AMEN1ALDH1A1KMT2A
Phenylacetic Acid SCHEMBL27735060 0.68 AKR1B1 (0.81) AKR1B1ABCC4LMNAGAATSHR
Phenylacetic Acid SCHEMBL28260960 0.68 AKR1B1 (0.81) AKR1B1ABCC4LMNAGAATSHR
SCHEMBL7604642 0.67 KDM4E (0.51) AKR1B1GAATSHRHPGDMEN1
SCHEMBL3080168 0.67 HPGD (0.54) TSHRHPGD
Phenylacetic Acid SCHEMBL11709776 0.66 AKR1B1 (0.94) AKR1B1ABCC4LMNAGAATSHR
SCHEMBL7612716 0.65 KDM4E (0.50) GAATSHRHPGDMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2002515040-A 2002-05-21 JP claimed
JP-2002514160-A 2002-05-14 JP claimed
EP-0954295-A1 METHODS OF CANCER TREATMENT USING NAALADASE INHIBITORS GUILFORD PHARMACEUTICALS INC. (US) 1999-11-10 EP claimed
EP-0936914-A1 HYDROXY-PHOSPHINYL DERIVATIVES USEFUL AS NAALADASE INHIBITORS GUILFORD PHARMACEUTICALS INC. (US) 1999-08-25 EP claimed
EP-0936914-A4 1999-08-25 EP claimed
WO-1997048400-A1 HYDROXY-PHOSPHINYL DERIVATIVES USEFUL AS NAALADASE INHIBITORS GUILFORD PHARMACEUTICALS INC. (US) 1997-12-24 WO claimed
WO-1997048409-A1 METHODS OF CANCER TREATMENT USING NAALADASE INHIBITORS GUILFORD PHARMACEUTICALS INC. (US) 1997-12-24 WO claimed
EP-0936914-A4 1999-08-25 EP disclosed
EP-0936914-A1 HYDROXY-PHOSPHINYL DERIVATIVES USEFUL AS NAALADASE INHIBITORS GUILFORD PHARMACEUTICALS INC. (US) 1999-08-25 EP disclosed
WO-1997048400-A1 HYDROXY-PHOSPHINYL DERIVATIVES USEFUL AS NAALADASE INHIBITORS GUILFORD PHARMACEUTICALS INC. (US) 1997-12-24 WO disclosed